A Proof of Concept Study of Pradigastat in Patients With Functional Constipation
Public ClinicalTrials.gov record NCT04620161. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Efficacy, Safety and Tolerability of Pradigastat in Patients With Functional Constipation
Study identification
- NCT ID
- NCT04620161
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Anji Pharma
- Industry
- Enrollment
- 181 participants
Conditions and interventions
Conditions
Interventions
- Pradigastat Tablets 20mg Drug
- Pradigastat Tablets 40mg Drug
- Pradigastat Tablets 20mg matching Placebo Drug
- Pradigastat Tablets 40mg matching Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 21, 2020
- Primary completion
- Apr 29, 2022
- Completion
- Jun 2, 2022
- Last update posted
- Aug 23, 2022
2020 – 2022
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Clinical Research-Meridian | Meridian | Idaho | 99202 | — |
| Evanston Premier Healthcare Research | Evanston | Illinois | 60201 | — |
| Jubilee Clinical Research | Las Vegas | Nevada | 89106 | — |
| Long Island Gastrointestinal Research Group LLP | New York | New York | 60201 | — |
| PMG Research of Charleston | Mt. Pleasant | South Carolina | 29464 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04620161, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04620161 live on ClinicalTrials.gov.